Department of Genetics, Stanford University, Stanford, CA, 94305, USA.
Department of Cell & Developmental Biology, University of Illinois Urbana-Champaign, Urbana, IL, 61801, USA.
Nat Commun. 2022 May 30;13(1):3007. doi: 10.1038/s41467-022-30323-6.
RNA polymerase III (Pol III) includes two alternate isoforms, defined by mutually exclusive incorporation of subunit POLR3G (RPC7α) or POLR3GL (RPC7β), in mammals. The contributions of POLR3G and POLR3GL to transcription potential has remained poorly defined. Here, we discover that loss of subunit POLR3G is accompanied by a restricted repertoire of genes transcribed by Pol III. Particularly sensitive is snaR-A, a small noncoding RNA implicated in cancer proliferation and metastasis. Analysis of Pol III isoform biases and downstream chromatin features identifies loss of POLR3G and snaR-A during differentiation, and conversely, re-establishment of POLR3G gene expression and SNAR-A gene features in cancer contexts. Our results support a model in which Pol III identity functions as an important transcriptional regulatory mechanism. Upregulation of POLR3G, which is driven by MYC, identifies a subgroup of patients with unfavorable survival outcomes in specific cancers, further implicating the POLR3G-enhanced transcription repertoire as a potential disease factor.
RNA 聚合酶 III(Pol III)包括两种交替的同工型,它们通过亚基 POLR3G(RPC7α)或 POLR3GL(RPC7β)的相互排斥性掺入来定义,在哺乳动物中。POLR3G 和 POLR3GL 对转录潜力的贡献仍然定义不明确。在这里,我们发现亚基 POLR3G 的缺失伴随着 Pol III 转录的基因谱受到限制。特别是 snaR-A,一种与癌症增殖和转移有关的小非编码 RNA,非常敏感。对 Pol III 同工型偏倚和下游染色质特征的分析表明,POLR3G 和 snaR-A 在分化过程中丢失,相反,POLR3G 基因表达和 SNAR-A 基因特征在癌症环境中重新建立。我们的结果支持这样一种模型,即 Pol III 的身份作为一种重要的转录调节机制发挥作用。由 MYC 驱动的 POLR3G 的上调,在特定癌症中确定了具有不良生存结果的患者亚组,这进一步暗示了 POLR3G 增强的转录谱可能是一个潜在的疾病因素。